Definitive Contract HDTRA116C0025

This federal contract award, with ID HDTRA116C0025, was issued by the Defense Threat Reduction Agency (DTRA) to The Trustees of Princeton University, a private non-profit research university, for the development of an "Ultrasensitive Rapid Ebola Virus Antigen Diagnostic Assay" during the base period. The $5,567,820.56 definitive contract has a cost-no-fee pricing type and a completion date of October 1, 2019. It did not have a set-aside designation.

The prime contractor, Princeton University, is a leading research institution that has been awarded numerous federal contracts and grants across a wide range of scientific and technological domains. In this case, Princeton is overseeing the scientific program and assuring the attainment of goals and metrics, including data collection, analysis, reporting, and budget adherence. Princeton has subcontracted a portion of the work to The Geneva Foundation, a non-profit organization focused on medical research and development for the federal government, particularly the Department of Defense.